RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Rxsight Inc. (RXST)
Market is closed
Sector: Ophthalmic Goods
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 3,702,967 | $48,138,571 | -2% | 0.81% |
| 2. | D E Shaw D. E. Shaw | 1,321,330 | $17,177,290 | +5907% | 0.01% |
| 3. | No Street Capital Jeff Osher | 1,200,000 | $15,600,000 | +100% | 1.15% |
| 4. | Citadel Investment Group Ken Griffin | 1,027,863 | $13,362,219 | +347% | 0% |
| 5. | Millennium Management Israel Englander | 951,177 | $12,365,301 | +6% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.13 | 1,767 | $55,004.24 | 3,210 | 2025-01-16 | Filing | |
| $31.19 | 1,443 | $44,999.96 | 1,443 | 2025-01-15 | Filing | |
| $44.50 | 1,705 | $75,872.50 | 38,438 | 2024-11-13 | Filing | |
| $44.98 | 4,090 | $183,968.20 | 36,733 | 2024-11-13 | Filing | |
| $45.00 | 5,570 | $250,650.00 | 474,141 | 2024-11-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.71 | 7,000 | $180,001.50 | 24,793 | 2025-03-12 | Filing | |
| $30.87 | 3,519 | $108,618.16 | 7,383 | 2025-01-22 | Filing | |
| $46.08 | 3,105 | $143,078.40 | 42,246 | 2024-11-29 | Filing | |
| $45.88 | 3,782 | $173,518.16 | 10,902 | 2024-11-26 | Filing | |
| $45.88 | 3,100 | $142,228.00 | 42,246 | 2024-11-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,007,110 | $39,092,430 | 0% | |
| 2. | 2,278,465 | $29,620,045 | 0% | |
| 3. | 2,252,544 | $29,283,072 | 0.04% | |
| 4. | 1,229,262 | $15,980,406 | 0.01% | |
| 5. | 1,119,240 | $14,550,120 | 0.42% |
News See All
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued
Wells Fargo upgraded RxSight Inc. (NASDAQ:RXST) from Equal Weight to Overweight on Monday, while raising its price target from $17 to $25 due to an attractive valuation at the current stock price.
RxSight, Inc. (NASDAQ:RXST) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to RxSight, Inc.
Do You Believe in the Long-Term Growth Potential of RxSight (RXST)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded...
RxSight, Inc. (NASDAQ:RXST) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Andrea, and I will be your conference operator today.
10 Most Promising Small-Cap Stocks According to Hedge Funds
Small-cap stocks are offering a myriad of opportunities to investors and are expected to go higher.
Top Investors' Stock Portfolio: 7 Small-Cap Stocks to Invest In
The market experts opine that strong and stable earnings growth, a favourable valuation environment and the expectation of lower interest rates provide a supportive environment for global small-cap equities...
RxSight, Inc. (NASDAQ:RXST) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript
RxSight, Inc. misses on earnings expectations. Reported EPS is $-0.24699 EPS, expectations were $-0.17.
RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript
RxSight, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.36.
Billionaire Hedge Funds
